Preclinical development of 1B7/CD3, a novel antiTSLPR bispecific antibody that targets CRLF2-rearranged Ph-like B-ALL (vol 37, pg 2006, 2023)

LEUKEMIA(2024)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要